Literature DB >> 8630286

A predictive index of axillary nodal involvement in operable breast cancer.

M De Laurentiis1, C Gallo, S De Placido, F Perrone, G Pettinato, G Petrella, C Carlomagno, L Panico, P Delrio, A R Bianco.   

Abstract

We investigated the association between pathological characteristics of primary breast cancer and degree of axillary nodal involvement and obtained a predictive index of the latter from the former. In 2076 cases, 17 histological features, including primary tumour and local invasion variables, were recorded. The whole sample was randomly split in a training (75% of cases) and a test sample. Simple and multiple correspondence analysis were used to select the variables to enter in a multinomial logit model to build an index predictive of the degree of nodal involvement. The response variable was axillary nodal status coded in four classes (N0, N1-3, N4-9, N > or = 10). The predictive index was then evaluated by testing goodness-of-fit and classification accuracy. Covariates significantly associated with nodal status were tumour size (P < 0.0001), tumour type (P < 0.0001), type of border (P = 0.048), multicentricity (P = 0.003), invasion of lymphatic and blood vessels (P < 0.0001) and nipple invasion (P = 0.006). Goodness-of-fit was validated by high concordance between observed and expected number of cases in each decile of predicted probability in both training and test samples. Classification accuracy analysis showed that true node-positive cases were well recognised (84.5%), but there was no clear distinction among the classes of node-positive cases. However, 10 year survival analysis showed a superimposible prognostic behaviour between predicted and observed nodal classes. Moreover, misclassified node-negative patients (i.e. those who are predicted positive) showed an outcome closer to patients with 1-3 metastatic nodes than to node-negative ones. In conclusion, the index cannot completely substitute for axillary node information, but it is a predictor of prognosis as accurate as nodal involvement and identifies a subgroup of node-negative patients with unfavourable prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8630286      PMCID: PMC2074509          DOI: 10.1038/bjc.1996.238

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

Review 1.  Correspondence analysis in medical research.

Authors:  M Greenacre
Journal:  Stat Methods Med Res       Date:  1992       Impact factor: 3.021

2.  Subclavicular biopsy as a guideline for the treatment of breast cancer.

Authors:  J A van Dongen
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

3.  A technique for using neural network analysis to perform survival analysis of censored data.

Authors:  M De Laurentiis; P M Ravdin
Journal:  Cancer Lett       Date:  1994-03-15       Impact factor: 8.679

4.  The need to reexamine axillary lymph node dissection in invasive breast cancer.

Authors:  B Cady
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

5.  Axillary surgery in breast cancer--there still is a debate.

Authors:  R G Margolese
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Axillary surgery in breast cancer: what debate?

Authors:  I S Fentiman
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  A review of goodness of fit statistics for use in the development of logistic regression models.

Authors:  S Lemeshow; D W Hosmer
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

8.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

9.  Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis.

Authors:  M Chadha; A B Chabon; P Friedmann; B Vikram
Journal:  Cancer       Date:  1994-01-15       Impact factor: 6.860

10.  Axillary sampling in the definitive treatment of breast cancer by radiation therapy and lumpectomy.

Authors:  C M Rose; L E Botnick; M Weinstein; J R Harris; C Koufman; W Silen; S Hellman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

View more
  2 in total

1.  A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

Authors:  Gabriele Martelli; Patrizia Boracchi; Michaela De Palo; Silvana Pilotti; Saro Oriana; Roberto Zucali; Maria Grazia Daidone; Giuseppe De Palo
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

2.  Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.

Authors:  O O Mohamed; P M Neary; C Fiuza-Castineira; G T O'Donoghue
Journal:  Ir J Med Sci       Date:  2014-03-02       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.